Edit
ProFibrix
http://www.profibrix.com/Last activity: 05.08.2013
Probably Closed - Reference to Internet Tepat
ProFibrix has developed Fibrocaps™, a new tissue sealant that stops acute and severe bleeding during surgery or due to trauma injury.
Fibrocaps™ is ready-to-use and can be applied in various ways, including in sprays or bandages. Fibrocaps™ has successfully been tested and will be launched after approval in the United States and Europe, which is expected in 2015. Annual peak revenues of Fibrocaps™ are expected to surpass $300 million.
Gilde acted as lead investor in its largest financing round. The company has since strengthened the organization, advanced its product pipeline, and clinically validated Fibrocaps™. The company was acquired by The Medicines Company (NASDAQ: MDCO) in 2013.
Profibrix is located in Leiden, the Netherlands, and Seattle, Washington.
Fibrocaps™ is ready-to-use and can be applied in various ways, including in sprays or bandages. Fibrocaps™ has successfully been tested and will be launched after approval in the United States and Europe, which is expected in 2015. Annual peak revenues of Fibrocaps™ are expected to surpass $300 million.
Gilde acted as lead investor in its largest financing round. The company has since strengthened the organization, advanced its product pipeline, and clinically validated Fibrocaps™. The company was acquired by The Medicines Company (NASDAQ: MDCO) in 2013.
Profibrix is located in Leiden, the Netherlands, and Seattle, Washington.
Location: Netherlands, South Holland, Leiden
Total raised: $33.69M
Investors 1
| Date | Name | Website |
| - | Gilde Heal... | gildehealt... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 03.05.2011 | - | $22.25M | - |
| 24.08.2009 | Series B | $11.44M | Gilde Heal... |
Mentions in press and media 6
| Date | Title | Description |
| 05.08.2013 | Medicines Buys ProFibrix, Led by Former Zymonite, for $90M | Share Share on Facebook Share on Twitter LinkedIn Email Reprints [Updated: 4:55 pm PT] ProFibrix, the Netherlands-based biotech company with a Seattle drug development office, has agreed to be acquired by The Medicines Company for $240 mill... |
| 21.06.2011 | ExtraHop, Profibrix, Avalara Lead Way Toward $70M in Equity Deals for WA Companies in May | Share Share on Facebook Share on Twitter LinkedIn Email Reprints Companies working on IT management, drug development, and software of all kinds led the way to about $70 million worth of equity deals in Washington state during May, accordin... |
| 03.05.2011 | Profibrix Raises EUR 15 Million | LEIDEN, THE NETHERLANDS and SEATTLE, US - ProFibrix B.V., a leader in the development of innovative products that help stop bleeding (hemostasis) after surgery, today announced the successful closing of a series B follow-on financing. In co... |
| 03.05.2011 | ProFibrix Closes Series B Financing | ProFibrix B.V., a Leiden, The Netherlands-based developer of innovative products that help stop bleeding (hemostasis) after surgery, closed a series B follow-on financing of undisclosed amount. The round was co-led by new investors Vesalius... |
| 26.08.2009 | ProFibrix closes a $11m Funding Round | ProFibrix, a Netherlands-based developer of innovative products for hemostasis and regenerative medicine, closed a $11m series B investment in an operation led by new investor Gilde Healthcare Partners, an European life sciences investor an... |
| 24.08.2009 | Gilde Healthcare Partners leads EUR 8 million series B financing in Profibrix B.V. | LEIDEN, THE NETHERLANDS and SEATTLE, WA - ProFibrix B.V., a leader in the development of innovative products for hemostasis and regenerative medicine, today announced the successful closing of a EUR 8 million series B investment. The financ... |